Literature DB >> 35767330

Authors' Reply to: To Screen or Not to Screen? At Which BMI Cut Point? Comment on "Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study".

Luke Funk1,2, Natalie Liu1.   

Abstract

Entities:  

Keywords:  BMI; anxiety; body mass index; chronic disease; depression; health services; heart disease; myocardial perfusion imaging; obesity; risk factors; screening

Mesh:

Year:  2022        PMID: 35767330      PMCID: PMC9280457          DOI: 10.2196/39717

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   7.076


× No keyword cloud information.
We thank our colleague from Greece [1] for her interest in our article [2]. Similar to our study, Fotopoulos et al [3] found an association between obesity and coronary artery disease (CAD) in their analysis of patients undergoing cardiac stress tests. They also reported that the presence of obesity and depression together was associated with CAD. Similarly, the presence of obesity and anxiety together was associated with CAD. Our study did not explicitly measure associations between depression and CAD or anxiety and CAD, but Sioka [1] raised important points about how obesity, mental health, and heart disease may interact. In the adjusted quantile regression analyses (Multimedia Appendix 4 of our paper), we found that patients with a diagnosis of anxiety had a similar BMI as those without anxiety. One systematic review of the literature suggested a positive association between obesity and anxiety, although a causal relationship has not been established [4]. Patients in our study who had a diagnosis of depression had a slightly higher median BMI than those without depression (0.74 BMI points, 95% CI 0.53-0.94). A meta-analysis of 15 longitudinal studies concluded that obesity increased the risk of depression, and depression was predictive of developing obesity [5]. Our study [2] and the study by Fotopoulos and colleagues [3] both reinforce the concept that obesity is associated with negative health outcomes that affect numerous body systems. Incorporating BMI into screening guidelines for conditions like CAD may help identify high-risk individuals so they can be intervened on earlier than current guidelines support.
  5 in total

Review 1.  The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis.

Authors:  G Gariepy; D Nitka; N Schmitz
Journal:  Int J Obes (Lond)       Date:  2009-12-08       Impact factor: 5.095

Review 2.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.

Authors:  Floriana S Luppino; Leonore M de Wit; Paul F Bouvy; Theo Stijnen; Pim Cuijpers; Brenda W J H Penninx; Frans G Zitman
Journal:  Arch Gen Psychiatry       Date:  2010-03

3.  Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study.

Authors:  Natalie Liu; Jen Birstler; Manasa Venkatesh; Lawrence Hanrahan; Guanhua Chen; Luke Funk
Journal:  J Med Internet Res       Date:  2021-08-09       Impact factor: 7.076

4.  To Screen or Not to Screen? At Which BMI Cut Point? Comment on "Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study".

Authors:  Chrissa Sioka
Journal:  J Med Internet Res       Date:  2022-06-29       Impact factor: 7.076

5.  The impact of depression and anxiety in prognosis of patients undergoing myocardial perfusion imaging with 99mTc tetrofosmin SPECT for evaluation of possible myocardial ischemia.

Authors:  Andreas Fotopoulos; Petros Petrikis; Ioannis Iakovou; Athanasios Papadopoulos; Konstantinos Sakelariou; Evangelia Gkika; Lampros Lakkas; Christos Touzios; Konstantinos Pappas; Antonios Klaroudas; Argyrios Doumas; Chrissa Sioka
Journal:  Nucl Med Rev Cent East Eur       Date:  2020
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.